Potentials and challenges of Levodopa particle formulation for treatment of Parkinson’s disease through intranasal and pulmonary delivery
Sign Up to like & getrecommendations! Published in 2020 at "Advanced Powder Technology"
DOI: 10.1016/j.apt.2020.03.028
Abstract: Abstract Inhalation drug delivery has gained interests in delivery of Levodopa for the treatment of Parkinson’s disease. In comparison to traditional oral delivery, delivery via intranasal or pulmonary pathways allows a slower drug degradation, greater… read more here.
Keywords: intranasal pulmonary; delivery; treatment parkinson; levodopa particle ... See more keywords